Market Overview

Afternoon Market Gainers

Share:
Related BLUE
Benzinga's Top Upgrades, Downgrades For August 17, 2017
Benzinga's Top Upgrades, Downgrades For July 27, 2017
Related NKTR
Benzinga's Top Upgrades, Downgrades For August 7, 2017
Are Options Traders Betting On A Big Move In Nektar Stock?

Bluebird Bio (NASDAQ: BLUE) traded up 49.55 percent to $25.41. Wednesday's IPO for the company was initially priced at $17.

Nektar Therapeutics (NASDAQ: NKTR) rose 9.99 percent to $10.79 after announcing positive top-line results from a human abuse liability (HAL) study for NKTR-181.

Gevo (NASDAQ: GEVO) climbed 9.23 percent to $2.26 after yesterday's announcement that it had resumed commercial production of Isobutanol.

Keryx BioPharma (NASDAQ: KERX) shot up 6.50 percent to $8.16 after analysts at JP Morgan initiated coverage on the stock with an Overweight rating.

MannKind (NASDAQ: MNKD) regained 6.48 percent to $7.03 after yesterday's double-digit drop.

Posted-In: News Movers

 

Related Articles (GEVO + BLUE)

View Comments and Join the Discussion!